The Cohort Study of Uveitis Patients

The Cohort Study of Uveitis Patients Based on Real-world Data

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05727540

Enrollment

600

Registered

2023-02-14

Start date

2023-02-20

Completion date

2026-03-31

Last updated

2024-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uveitis

Brief summary

This study intends to explore the epidemiology, pathogenesis, clinical manifestations, diagnosis and treatment of uveitis. This is a cohort study. The outcome of the study is the activity of inflammation and visual prognosis. The purpose of this study is to determine the optimal diagnosis and treatment scheme for uveitis patients based on real-world data.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* The diagnosis is uveitis; The agreement of enrolling this study;

Exclusion criteria

* Uveitis during the first month after any intraocular surgery; \<18 years; pregnant and lactating women; other conditions are unsuitable for participation in this study by the investigator such as mental abnormalities.

Design outcomes

Primary

Measure	Time frame	Description
The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system	12 months post-treatment	activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions	12 months post-treatment	inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography

Secondary

Measure	Time frame	Description
The number of Intraocular pressure	12 months post-treatment	The number of Intraocular pressure was examed by non-contact tonometer
Central retinal thickness	1 month post-treatment	Central retinal thickness was evaluated by Optical Coherence Tomography
Best corrected visual acuity	1 month post-treatment	Best corrected visual acuity
The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions	3 months post-treatment	inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography
The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system	1 month post-treatment	activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
The number of intraocular pressure	1 month post-treatment	The number of Intraocular pressure was examed by non-contact tonometer

Countries

China

Contacts

Primary ContactYe Dai, doctor

daiye@gzzoc.com13512721192

Outcome results